Compare AKBA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | XPOF |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 278.9M |
| IPO Year | 2014 | 2021 |
| Metric | AKBA | XPOF |
|---|---|---|
| Price | $1.22 | $6.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | $4.67 | ★ $8.13 |
| AVG Volume (30 Days) | ★ 4.1M | 637.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.94 | 35.24 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $11,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $3.83 |
| 52 Week High | $3.81 | $11.09 |
| Indicator | AKBA | XPOF |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 42.03 |
| Support Level | $1.16 | $5.33 |
| Resistance Level | $1.52 | $7.11 |
| Average True Range (ATR) | 0.07 | 0.30 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 7.59 | 25.32 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.